MGX vs QRVO · rev $25.2M vs P/E 27, rev $3.68B
Metagenomi, Inc. Common Stock (MGX) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
MGX currently screens at market cap $44.4M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the MGX and QRVO stock pages for the full models.
Not investment advice.